Figure 5.
Resiquimod dose vaccine study with medium sized MC. Mice were immunized on Day 0 (prime) and Day 21 (boost). Blood draws were done on Days −7 and 28. Total IgG (A), IgG1 (B), and IgG2c (C) endpoint anti-OVA antibody titers from day 28. Titers were log transformed and represented as mean ± standard deviation. ***p < 0.0005, ****p < 0.0001 for comparisons to soluble resiquimod dose counterpart. +p < 0.05, ++p < 0.01, ++++p < 0.0001 for comparisons to OVA only.